DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 776 filers reported holding DANAHER CORPORATION in Q2 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $250,000 | -89.2% | 933 | -94.7% | 0.11% | -89.1% |
| Q1 2019 | $2,317,000 | +13.6% | 17,552 | -11.3% | 0.97% | +2.1% |
| Q4 2018 | $2,039,000 | -23.1% | 19,777 | -19.0% | 0.95% | +34.6% |
| Q3 2018 | $2,652,000 | +4.8% | 24,405 | -4.8% | 0.71% | +0.6% |
| Q2 2018 | $2,531,000 | -1.9% | 25,646 | -2.7% | 0.70% | -3.8% |
| Q1 2018 | $2,580,000 | +5.9% | 26,346 | +0.3% | 0.73% | +12.9% |
| Q4 2017 | $2,437,000 | +8.6% | 26,256 | +0.4% | 0.65% | +7.8% |
| Q3 2017 | $2,243,000 | +5.1% | 26,142 | +3.4% | 0.60% | +3.3% |
| Q2 2017 | $2,134,000 | -10.9% | 25,292 | -9.6% | 0.58% | -1.9% |
| Q1 2017 | $2,394,000 | -19.9% | 27,992 | -27.0% | 0.59% | -15.6% |
| Q4 2016 | $2,987,000 | -0.7% | 38,367 | 0.0% | 0.70% | +1.3% |
| Q3 2016 | $3,008,000 | -22.4% | 38,367 | +0.0% | 0.70% | -26.5% |
| Q2 2016 | $3,874,000 | +4.0% | 38,357 | -2.3% | 0.94% | -6.4% |
| Q1 2016 | $3,724,000 | -5.0% | 39,260 | -6.9% | 1.01% | +3.0% |
| Q4 2015 | $3,918,000 | -2.4% | 42,188 | 0.0% | 0.98% | -8.1% |
| Q3 2015 | $4,016,000 | +69.8% | 42,188 | +63.3% | 1.07% | +28.2% |
| Q2 2015 | $2,365,000 | +10.3% | 25,828 | +2.3% | 0.83% | -0.7% |
| Q1 2015 | $2,144,000 | +16.6% | 25,250 | +17.8% | 0.84% | +11.3% |
| Q4 2014 | $1,838,000 | -44.4% | 21,439 | -50.7% | 0.75% | -42.1% |
| Q3 2014 | $3,305,000 | -1.2% | 43,503 | +2.4% | 1.30% | -10.0% |
| Q2 2014 | $3,346,000 | +4.4% | 42,494 | -0.5% | 1.45% | +11.4% |
| Q1 2014 | $3,204,000 | +8.4% | 42,714 | +11.5% | 1.30% | +0.4% |
| Q4 2013 | $2,957,000 | +4.9% | 38,304 | -5.8% | 1.30% | -3.0% |
| Q3 2013 | $2,818,000 | -5.5% | 40,649 | -13.7% | 1.34% | -13.4% |
| Q2 2013 | $2,982,000 | – | 47,107 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |